L-lysine-aescinat, ampoules, 1mg/ml, 5ml, 10pcs

Composition

Active ingredient:

L-lysine-aescinat;

Auxiliary substances:

water,

propylene glycol and 96% ethyl alcohol

Pharmacological action

Lysine Escinate is able to inhibit the activity of lysosomal hydrolases, which leads to a decrease in the rate of cleavage of mucopolysaccharides in connective tissue and the walls of small capillaries.

The drug has an analgesic effect, has an anti-edematous (anti-exudative) effect. During treatment, vascular tone and vascular-tissue permeability increase.

The drug has a moderately pronounced hypoglycemic effect.

Indications

• edema of the spinal cord, brain;
• displacement of the median structures of the brain;
• intracranial hematomas;
• subarachnoid hematomas;
• edema-swelling syndrome;
• edematous-painful vertebral syndromes;
• soft tissue edema with damage to the musculoskeletal system;
• edematous-painful syndromes of the trunk and extremities;
• disorders of venous outflow in the lower extremities in acute thrombophlebitis.

Contraindications

• of bleeding;
• pathology of the renal system;
• age limit-up to 18 years;
• individual hypersensitivity;
• breastfeeding;
• pregnancy period.

Side effects

Allergic responses:  fever; hyperemia and itching of the lips, face skin; skin rashes (erythema, petechiae, papules); anaphylactic shock; urticaria; angioedema.

The nervous system:  short-term loss of consciousness; dizziness; ataxia; tremor of the extremities; migraine headache.

The digestive tract:  increased ALT, AST, and bilirubin; diarrheal syndrome; vomiting; nausea.

Cardiovascular system:  unstable blood pressure; retrosternal pain; rapid heartbeat.

The respiratory tract:  bronchial obstruction; shortness of breath; lack of air; dry, unproductive cough.

Other reactions:  chills; severe weakness; phlebitis at the injection site; burning sensation during the procedure; feeling of heat; pain in the arm.

How to take, course of use and dosage

of L-lysine-aescinat can only be administered intravenously slowly. Intra-arterial use of the drug is unacceptable. The daily dose is 5-10 ml.

The infusion solution is prepared by mixing Na chloride (50-100 ml of 0.9% solution) and medication.

In rare cases, a jet infusion of the drug is allowed at a slow speed.

Instructions for use of L-lysine in life-threatening conditions (head injury, spinal cord edema, etc. ): double use of a 20 ml solution (total daily dose).

The course is designed for 2-8 days.

Lysine solution can only be stored in ampoules.

Form of production

Solution for intravenous use

Storage conditions

In a dark place, at a temperature of 15-25 °C

Shelf life

2 years

Active ingredient

Escina lysinate

Conditions of release from pharmacies

By prescription

Dosage form

solution for infusions

Description

Adults as prescribed by a doctor

Indications

Swelling after injuries and operations, Thrombophlebitis